An experimental inhaled therapy that aims to ease respiratory symptoms in people with cystic fibrosis (CF) has won orphan drug status in the European Union — a designation designed to speed the development of new medications for rare diseases. An arm of the European Medicines Agency (EMA) granted…
News
Pancreaze (pancrelipase), an approved therapy used to manage pancreatic complications in cystic fibrosis (CF), has been added as a preferred therapy on a National Medicare Part D formulary, according to the therapy’s maker, Vivus. The move means lower out-of-pocket costs for patients receiving the medication through Medicare, the…
CFTR modulators, a class of medications that boost the activity of a faulty CFTR protein in people with cystic fibrosis (CF), do not appear to increase the overall risk of depression, anxiety, or other neuropsychiatric symptoms in people with the genetic disorder, a U.S. study has found. The findings…
Changes in dietary fat intake did not affect mucus content or lung function in a study involving a rat model of cystic fibrosis (CF). The researchers said the findings suggest that fish oil supplements do not meaningfully affect lung outcomes in CF. The study also suggests that CF may…
Women who carry a mutation that can cause cystic fibrosis (CF) may be more likely to develop gestational diabetes, and carriers of certain CF-causing mutations may also have a harder time getting pregnant, according to a new study. “These results support the concept that [being a CF carrier] may…
A study linked long-term exposure to ozone, an air pollutant, to more severe sinus-related symptoms and a poorer sense of smell in adults with cystic fibrosis (CF) and chronic rhinosinusitis (CRS), a disorder marked by long-term inflammation in the nose and sinuses that is common in people with CF.
A new study identified four distinct patterns of digestive symptoms in adults with cystic fibrosis (CF), ranging from mild to severe and widespread symptoms. These patterns of symptoms showed “associations with [gastrointestinal] complications and medication requirements, suggesting distinct underlying [mechanisms] and a varying degree of involvement of complex gastrointestinal…
Many people with cystic fibrosis (CF) struggle with steep healthcare bills, but those who hesitate to discuss money with their doctors face the highest barriers to getting financial help, a U.S. survey has found. Patients often keep quiet simply because they do not know what questions to ask or…
People with cystic fibrosis (CF) and their caregivers want their CF care teams to help with school needs, including absences, accommodations, and infection control, according to a U.S. survey. The survey revealed common issues “that warrant targeted and proactive attention to support academic achievement and wellbeing,” the researchers wrote.
About 40% of people with cystic fibrosis (CF) taking CFTR modulators, a class of medication used to treat the genetic disorder, consider inhaled medicines less important after starting these meds, according to a U.K. survey. Many people attributed this change to improved health, fewer respiratory symptoms, or a lack…
Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.
Recent Posts
- I’m not unreliable, but my health is, so making plans can be difficult
- Mucus-targeting treatment for CF wins orphan drug status in Europe
- CF pancreatic treatment gets Medicare preferred status
- Switching places with my caregiver gave me a whole new perspective
- CFTR modulators not linked to higher psychiatric symptom risk in CF